Alexander Harms

931 citations
31 papers · 511 indexed · h-index 15
Topics
Cancer Genomics and Diagnostics (10 papers)Lung Cancer Treatments and Mutations (10 papers)Lung Cancer Diagnosis and Treatment (8 papers)

In The Last Decade

Alexander Harms

30 papers receiving 507 citations

Peers

Alexander Harms
Comparison fields: 5 of 62
  • Pulmonary and Respiratory Medicine 244
  • Oncology 183
  • Molecular Biology 165
  • Cancer Research 100
  • Surgery 99
Replace Katharina Kessel with:
Katharina Kessel Germany
K. Pigott United Kingdom
Guenther Gruber Switzerland
Andrea S. Fung Canada
Uta Eberlein Germany
Jeremy Sharib United States
Liru He China
D. Khayat France
Yushen Qian United States
Wen Lin China
Alexander Harms relative to Katharina Kessel Germany Katharina Kessel's profile →
Citations per field
00.5×5.7×
Katharina Kessel · 1×
Citations per year

Countries citing papers authored by Alexander Harms

Since Specialization
Citations

This map shows the geographic impact of Alexander Harms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Harms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Harms more than expected).

Fields of papers citing papers by Alexander Harms

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Harms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Harms. The network helps show where Alexander Harms may publish in the future.

Co-authorship network of co-authors of Alexander Harms

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Harms. A scholar is included among the top collaborators of Alexander Harms based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Harms. Alexander Harms is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 2
4 2
5 5
6 18
7 1
8 29
9 24
10 30
11 8
12 5
13 3
14 4
15 7
16 3
17 25
18 63
19 29
20 42

About Alexander Harms

Alexander Harms is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 31 papers that have together received 511 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (10 papers), Lung Cancer Treatments and Mutations (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (244 citations), Oncology (183 citations) and Cancer Research (100 citations). Alexander Harms has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Arne Warth, Thomas Muley, Mark Kriegsmann, Hendrik Dienemann, Wilko Weichert, Daniel Kazdal, Peter Schirmacher, H. Winter, Albrecht Stenzinger and Douglas Flieder. Their work appears in journals such as PLoS ONE, European Heart Journal and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026